Genome-wide identification of genes required for alternative peptidoglycan cross-linking in Escherichia coli revealed unexpected impacts of β-lactams
β-lactam-induced bacterial killing is complex and not fully resolved. Authors carry out a genome-wide analysis, through penicillin-binding protein replacement, to identify genes essential for drug efficacy.
Main Authors: | Henri Voedts, Sean P. Kennedy, Guennadi Sezonov, Michel Arthur, Jean-Emmanuel Hugonnet |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-35528-3 |
Similar Items
-
Relationship between the Rod complex and peptidoglycan structure in Escherichia coli
by: Risa Ago, et al.
Published: (2023-10-01) -
COMMENSAL STRAINS OF ESCHERICHIA COLI AND BETA-LACTAM RESISTANCE
by: L. V. Suzhaeva, et al.
Published: (2018-12-01) -
Escherichia coli has robust regulatory mechanisms against elevated peptidoglycan cleavage by lytic transglycosylases
by: Liang, Yaquan, et al.
Published: (2024) -
Glycan strand cleavage by a lytic transglycosylase, MltD contributes to the expansion of peptidoglycan in Escherichia coli.
by: Moneca Kaul, et al.
Published: (2024-02-01) -
Characterization of Beta-Lactam Resistome of <i>Escherichia coli</i> Causing Nosocomial Infections
by: Rosalino Vázquez-López, et al.
Published: (2023-08-01)